BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34556131)

  • 1. Measuring the cognitive costs of the COVID-19 pandemic.
    Day GS
    Mol Neurodegener; 2021 Sep; 16(1):67. PubMed ID: 34556131
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results.
    Pirker-Kees A; Platho-Elwischger K; Hafner S; Redlich K; Baumgartner C
    Dement Geriatr Cogn Disord; 2021; 50(1):68-73. PubMed ID: 33853062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.
    D'Arrigo JS
    Am J Alzheimers Dis Other Demen; 2020; 35():1533317520976761. PubMed ID: 33307726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.
    Stefano GB; Büttiker P; Weissenberger S; Martin A; Ptacek R; Kream RM
    Med Sci Monit; 2021 May; 27():e933015. PubMed ID: 34016942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelial dysfunction in COVID- 19 and cognitive impairment].
    Martynov MY; Bogolepova AN; Yasamanova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(6):93-99. PubMed ID: 34283537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Aspects of COVID-19.
    Gonzalez-Fernandez E; Huang J
    Curr Neurol Neurosci Rep; 2023 Sep; 23(9):531-538. PubMed ID: 37490194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-19, neuroCOVID-19 and cognitive impairment in elderly and old patients (literature review).].
    Kurmaev DP; Bulgakova SV; Treneva EV; Kosareva OV; Sharonova LA; Dolgikh YA
    Adv Gerontol; 2023; 36(1):98-108. PubMed ID: 37192361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could COVID delirium bring on dementia?
    Arnold C
    Nature; 2020 Dec; 588(7836):22-24. PubMed ID: 33268868
    [No Abstract]   [Full Text] [Related]  

  • 9. The 'third wave': impending cognitive and functional decline in COVID-19 survivors.
    Baker HA; Safavynia SA; Evered LA
    Br J Anaesth; 2021 Jan; 126(1):44-47. PubMed ID: 33187638
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of COVID-19 pandemic on people with mild cognitive impairment/dementia and on their caregivers.
    Tsapanou A; Papatriantafyllou JD; Yiannopoulou K; Sali D; Kalligerou F; Ntanasi E; Zoi P; Margioti E; Kamtsadeli V; Hatzopoulou M; Koustimpi M; Zagka A; Papageorgiou SG; Sakka P
    Int J Geriatr Psychiatry; 2021 Apr; 36(4):583-587. PubMed ID: 33166418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Framework for Addressing Clients' Functional Cognitive Deficits After COVID-19.
    Watters K; Marks TS; Edwards DF; Skidmore ER; Giles GM
    Am J Occup Ther; 2021; 75(Supplement_1):7511347010p1-7511347010p7. PubMed ID: 34405800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 is Penetrating to Dementia Research.
    Bostanciklioğlu M
    Curr Neurovasc Res; 2020; 17(4):342-343. PubMed ID: 32442082
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cognitive Impairment as a Sequela of COVID-19: Pathophysiology and Prospects for Treatment].
    Shimohata T
    Rinsho Shinkeigaku; 2023 Nov; 63(11):725-731. PubMed ID: 37880112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive alterations in patients recovered from COVID-19 treated in Cardiopulmonary Rehabilitation].
    Domínguez-Paredes AL; Varela-Tapia CL; Dorado-Arias V; Salazar-Núñez E; Martínez-Barro D
    Rev Med Inst Mex Seguro Soc; 2023 Nov; 61(6):796-801. PubMed ID: 37995338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant cognitive impairment likely associated with COVID-19 infection with relatively nonsevere symptoms.
    Reeves RR; Willoughby SG
    J Osteopath Med; 2022 Jan; 122(3):119-123. PubMed ID: 35073472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients.
    Haji Akhoundi F; Sahraian MA; Naser Moghadasi A
    Mult Scler Relat Disord; 2020 Jun; 41():102164. PubMed ID: 32388452
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential for Cognitive Communication Impairment in COVID-19 Survivors: A Call to Action for Speech-Language Pathologists.
    Ramage AE
    Am J Speech Lang Pathol; 2020 Nov; 29(4):1821-1832. PubMed ID: 32946270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.